Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease.

Drug development for rare diseases can be long, complex, and costly. Desmoid tumors (DT), a rare type of soft-tissue tumor, are associated with substantial and debilitating burden, including disease-specific symptoms (e.g.